Bispecific fusion protein and method of use for enhancing effector cell killing of target cells

Details for Australian Patent Application No. 2001265418 (hide)

Owner Biogen Idec Inc.

Inventors Hanna, Nabil

Agent Shelston IP

Pub. Number AU-B-2001265418

PCT Pub. Number WO01/97844

Priority 60213252 22.06.00 US

Filing date 4 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 30 March 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

4 November 2004 Change of Name(s) of Applicant(s), Section 104

  Idec Pharmaceuticals Corporation The name of the applicant has been changed to Biogen Idec Inc.

30 March 2006 Application Accepted

  Published as AU-B-2001265418

27 July 2006 Standard Patent Sealed

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001265419-No wash bead assay, kit and procedure

2001265417-Compositions and methods for the endocytic presentation of immunosuppressive factors